Inhaled Nitric Oxide Market Size, Share & Forecast to 2032

The inhaled nitric oxide market is undergoing significant transformation, driven by advancements in clinical protocols, evolving regulatory requirements, and a shift toward innovative delivery systems. Senior leaders must continually adapt strategies to maintain reliable therapeutic access and operational efficiency in acute care environments.

Market Snapshot

The inhaled nitric oxide market expanded from USD 871.37 million in 2025 to USD 917.53 million in 2026. With an anticipated CAGR of 6.03%, the market is projected to reach USD 1.31 billion by 2032. This growth is anchored in rising clinical demand for pulmonary vasodilation therapy, expanded use in neonatal and critical care, and continued innovation in both hospital-based and portable delivery solutions. Senior decision-makers are re-evaluating procurement models, delivery formats, and partnership approaches to remain resilient in a changing supply and regulatory landscape.

Scope & Segmentation

Product Delivery Formats: Cylinder-based systems remain essential for immediate bedside use; on-site generators are increasingly adopted for logistics efficiency and supply reliability; tanker deliveries support large-scale centralized operations.
Clinical Applications: Includes management of adult idiopathic and secondary pulmonary hypertension, acute respiratory distress syndromes, and neonatal pulmonary hypertension—each with distinct workflow and support requirements.
End-User Segments: Encompasses hospitals, ambulatory surgical centers, specialty clinics, and the growing homecare segment, each presenting unique procurement, staff training, and device integration needs.
Distribution Channels: Direct tenders, distribution partners, and online procurement routes enable flexible access and tailored aftersales support.
Regional Markets: Analysis covers Americas, Europe, Middle East & Africa, and Asia-Pacific, spotlighting regulatory heterogeneity, infrastructure maturity, and distribution sophistication as key drivers of differentiated market strategies.
Technology Developments: Maturation of on-site generator systems, digital monitoring tools, interoperability with ventilators and ECMO, and miniaturized solutions for portable care settings.

Key Takeaways

Delivery innovation and integration with critical care platforms are reshaping provider decisions and capital investments, especially as clinical protocols emphasize precision and adaptability.
Collaboration between device manufacturers, clinical engineering teams, and healthcare staff is key for ensuring seamless system compatibility and supporting protocol-driven therapy decisions.
Expanded homecare and ambulatory opportunities are influencing demand for compact, safe, and user-friendly delivery technologies, while hospitals continue to require robust, scalable infrastructure.
Quality assurance, regulatory compliance, and outcome-based monitoring are central to vendor selection and long-term service contracts.
Strategic supplier partnerships and flexible commercial terms, such as managed service agreements and performance-based arrangements, increasingly influence buying decisions and market share dynamics.

Tariff Impact

Tariff changes affect sourcing costs for imported cylinders, generators, and critical components, compelling manufacturers to adjust pricing, review contracts, and consider localization of production. Healthcare systems may need to assess on-site generation or domestic procurement agreements to mitigate cost volatility and supply risk. Tariff-induced price changes can also drive refinement of dosing protocols and tighter documentation, while partners may offer risk-sharing contracts or managed inventory solutions to stabilize end-user expenses.

Methodology & Data Sources

This analysis encompasses structured interviews with clinicians, procurement leaders, and technical professionals, combined with secondary research into regulatory filings, clinical guidelines, peer-reviewed literature, and supply chain reviews. Scenario analysis was employed to test resilience under cost and supply shifts, ensuring robust, actionable insights informed by direct stakeholder perspectives and real-world operational data.

Why This Report Matters

Enables senior executives to benchmark delivery models and procurement strategies in the inhaled nitric oxide market for optimized operational decisions.
Supports manufacturers and distributors positioning by revealing how regulatory, clinical, and distribution changes affect adoption and market access.
Delivers actionable guidance for mitigating supply risks, leveraging delivery innovation, and aligning purchasing with clinical and policy trends.

Conclusion

As clinical needs, technology, and procurement landscapes evolve, organizations that integrate clinical evidence, supply resilience, and flexible commercial approaches will be best positioned for sustained performance and reliable patient access in the inhaled nitric oxide ecosystem.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Inhaled Nitric Oxide Market, by Product

8.1. Cylinder
8.2. Generator
8.3. Tanker

9. Inhaled Nitric Oxide Market, by Distribution Channel

9.1. Direct Tender
9.2. Distribution Partner
9.3. Online

10. Inhaled Nitric Oxide Market, by Application

10.1. Adult Pulmonary Hypertension
10.1.1. Idiopathic
10.1.2. Secondary
10.2. Ards
10.2.1. Extracorporeal Membrane Oxygenation
10.2.2. Invasive Ventilation
10.3. Neonatal Pulmonary Hypertension
10.3.1. Extracorporeal Membrane Oxygenation
10.3.2. Mechanical Ventilation

11. Inhaled Nitric Oxide Market, by End User

11.1. Online
11.2. Offline

12. Inhaled Nitric Oxide Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Inhaled Nitric Oxide Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Inhaled Nitric Oxide Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Inhaled Nitric Oxide Market
16. China Inhaled Nitric Oxide Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Air Liquide S.A.
17.6. BOC Ltd.
17.7. Circassia Pharmaceuticals plc
17.8. Ikaria, Inc.
17.9. Linde plc
17.10. Mallinckrodt plc
17.11. Messer Group GmbH
17.12. Novoteris, LLC
17.13. Praxair, Inc.
17.14. VERO Biotech LLC

List of Figures

FIGURE 1. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA INHALED NITRIC OXIDE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CYLINDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CYLINDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CYLINDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY GENERATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY GENERATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY GENERATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TANKER, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TANKER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TANKER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION PARTNER, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION PARTNER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION PARTNER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY IDIOPATHIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY IDIOPATHIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY IDIOPATHIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY SECONDARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY SECONDARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY SECONDARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY INVASIVE VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY INVASIVE VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MECHANICAL VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MECHANICAL VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 95. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 99. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 111. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 114. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 115. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 116. AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 128. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 131. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 132. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 133. ASEAN INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. GCC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GCC INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 136. GCC INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. GCC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. GCC INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 139. GCC INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 140. GCC INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 141. GCC INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 152. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 155. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 156. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 157. BRICS INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. G7 INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. G7 INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 160. G7 INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. G7 INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. G7 INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 163. G7 INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 164. G7 INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 165. G7 INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. NATO INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. NATO INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 168. NATO INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. NATO INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. NATO INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 171. NATO INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 172. NATO INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 173. NATO INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. CHINA INHALED NITRIC OXIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 184. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 185. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 188. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2032 (USD MILLION)
TABLE 189. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2032 (USD MILLION)
TABLE 190. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Inhaled Nitric Oxide market report include:

Air Liquide S.A.
BOC Ltd.
Circassia Pharmaceuticals plc
Ikaria, Inc.
Linde plc
Mallinckrodt plc
Messer Group GmbH
Novoteris, LLC
Praxair, Inc.
VERO Biotech LLC

Table Information

Report Attribute	Details
No. of Pages	186
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 917.53 Million
Forecasted Market Value ( USD ) by 2032	$ 1310 Million
Compound Annual Growth Rate	6.0%
Regions Covered	Global
No. of Companies Mentioned	11

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3471EUR$3,939USD£3,022GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3745EUR$4,249USD£3,259GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5075EUR$5,759USD£4,418GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6142EUR$6,969USD£5,346GBP

Inhaled Nitric Oxide Market - Global Forecast 2026-2032

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Inhaled Nitric Oxide Market Size, Share, Trends and Forecast by Application and Region, 2025-2033

Inhaled Nitric Oxide Delivery Systems - Global Strategic Business Report

Inhaled Nitric Oxide Delivery System Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Inhaled Nitric Oxide Delivery Systems Market - Global Forecast 2026-2032

Inhaled Nitric Oxide Delivery Device Market - Global Forecast 2025-2030

About the Market